The novel approach of the medication represents a major breakthrough in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatide-peptide317194.blogpostie.com/63255052/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment